News | Artificial Intelligence | April 02, 2020

The web-based services available for free for anyone who wants to use our AI algorithms to analyze a chest X-ray or CT scan

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once

April 2, 2020 — In the face of the COVID-19 pandemic raging around the globe, Vuno has decided to move quickly by joining the global coalition to help address some critical issues facing the international healthcare community today by putting artificial intelligence (AI) into work. A spokesperson said that Vuno has been inundated with requests over the last several weeks regarding how it can help doctors remain resilient and better respond to the spread of the infection and ultimately contribute to saving lives.

In an effort to help the medical community, Vuno has accelerated the development and enhancement of its exiting AI algorithms to better meet the specific needs and demands from exhausted doctors who willingly put themselves at risk to save lives in the fight against COVID-19.

With that mission in mind, the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once. Our one-stop service offering will allow users to choose one or both algorithms to use depending on their own needs by simply visiting one website without the hassle of moving from different AI systems.

The special versions of two AI products for COVID-19 were released this week. These are web-based services available at https://covid19.vunomed.com/ for free for anyone who wants to use theAI algorithms to analyze a chest X-ray or CT scan.

AI Solutions Offered

The common theme of the two AI solutions is to empower healthcare providers to provide better patient care by assisting them in the screening, diagnosis and management of COVID-19 infected patients using our AI technology. They are developed to help protect healthcare providers from burnout or help overworked doctors on the edge of exhaustion in virus fight make a speedier and more accurate diagnostic decision in a difficult time like now. In addition, our cloud-based service offering will enable remote result reading and tracking of the status of patients infected with COVID-19, where radiologists are not readily available.  

In Korea, two local governments in Gangwon Province and a major hospital in Daegu, the hardest-hit area are actively using VUNO Med-Chest X-ray in response to the outbreak. They stated that the instant and visualized results with a colored heatmap from the solution are very helpful to triage patients with suspected infection of the virus, especially when they cannot see the X-ray images clearly due to fogged goggles they have to wear all day long. 

Medical institutions and healthcare providers are encouraged to make the best use of the free online service offering available at https://covid19.vunomed.com/

Related Coronavirus Content:

Two Studies Use SIRD Model to Forecast COVID-19 Spread

Radiology Publishes First Case of COVID-19 Encephalopathy

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
Subscribe Now